7-103313085-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014377.3(DNAJC2):c.1653C>G(p.Phe551Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014377.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAJC2 | ENST00000379263.8 | c.1653C>G | p.Phe551Leu | missense_variant | Exon 16 of 17 | 1 | NM_014377.3 | ENSP00000368565.3 | ||
PMPCB | ENST00000249269.9 | c.*814G>C | 3_prime_UTR_variant | Exon 13 of 13 | 1 | NM_004279.3 | ENSP00000249269.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1653C>G (p.F551L) alteration is located in exon 16 (coding exon 16) of the DNAJC2 gene. This alteration results from a C to G substitution at nucleotide position 1653, causing the phenylalanine (F) at amino acid position 551 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.